Dx Deals: Quest Makes Big North American Expansion with LifeLabs Acquisition
The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada.
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada.
By Sean McSweeney bio
Today, laboratory billing claims require more and more data to successfully get paid.
One of the biggest reasons your claims may be getting denied is because…
From - Laboratory Industry Report
Laboratory diagnosis of Lyme disease is based on detecting the presence of antibodies against…
From - National Intelligence Report
It's an all too common occurrence. You or a loved one require an in-hospital procedure, but you have no idea of what the…
From - Lab Compliance Advisor
In addition to the usual Medicare and Medicaid anti-fraud laws, labs have a new liability risk to contend with…
From - National Intelligence Report
Laboratory diagnosis of Lyme disease is based on detecting the presence of antibodies against…
From - Laboratory Industry Report
Few of the newfangled consumer genetic testing products have had greater commercial success and…
From - Lab Compliance Advisor
On July 11, CMS announced the results of 2018, Year 2 under the Merit-based Incentive Payment System…
From - National Intelligence Report
The FDA has apparently set its enforcement sights on Laboratory Developed Tests (LDTs) that claim to predict…